OnKure Therapeutics, Inc.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
OKUR$2.87+13.5%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Financial Statements (Unaudited)
Item 1. Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.